You are here

Article Text

Article menu
Download PDFPDF
Treatment
Topical aqueous 2% lignocaine eardrops reduced ear pain in children with acute otitis media

https://doi.org/10.1136/ebn.11.4.107

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    F E Babl

    Dr F E Babl, Royal Children’s Hospital, Parkville, Victoria, Australia; franz.babl@rch.org.au

    QUESTION

    Are topical aqueous 2% lignocaine (lidocaine) eardrops effective for relieving ear pain in children with acute otitis media (AOM)?

    METHODS

    Design:

    randomised placebo controlled trial.

    Allocation:

    {concealed}.*

    Blinding:

    blinded (children, parents, clinicians administering treatment, and outcome assessors).

    Follow-up period:

    primary outcome was assessed at 10, 20, and 30 minutes.

    Setting:

    emergency department (ED) of a children’s hospital in Australia.

    Patients:

    63 children 3–17 years of age (mean age 6 y, 51% girls) who had ear pain lasting <3 days and signs of AOM (tympanic membrane with erythema, dullness, and bulging appearance). Children with evidence of tympanic membrane perforation, ventilation tubes in situ, allergy to local anaesthetic or …

    View Full Text

    Footnotes

    • Source of funding: in part, Victor Smorgon Charitable Fund.